MOZ: double bogey.
Mozz response is faulty on at least two points.
Point 1: PAR is no longer “fast track”. The slow postponed FDA response clearly demonstrates this. NOT GOOD NEWS.
Point 2: Claims of magnificent PAR generated data are not supported by any publications in leading OA journals. NOTHING but promises- promises- promises. MaRVeL oral PPS publication in British Medical Journal – open, a peer reviewed article. Is PAR data package amateur flawed and non-compliant. NOT GOOD NEWS.
https://anzctr.org.au/Trial/Registration/TrialReview.aspx?ACTRN=12621000654853
https://bmjopen.bmj.com/content/bmjopen/14/5/e083046.full.pdf
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9985017/
https://www.sydney.edu.au/medicine-health/about/our-people/academic-staff/david.hunter.html
DYOR. Just an opinion.
- Forums
- ASX - By Stock
- Over PAR
MOZ: double bogey. Mozz response is faulty on at least two...
-
- There are more pages in this discussion • 16 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PAR (ASX) to my watchlist
(20min delay)
|
|||||
Last
19.0¢ |
Change
-0.010(5.00%) |
Mkt cap ! $66.54M |
Open | High | Low | Value | Volume |
20.0¢ | 21.0¢ | 19.0¢ | $203.4K | 1.019M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
14 | 387930 | 19.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
20.5¢ | 65468 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
13 | 384246 | 0.190 |
3 | 57000 | 0.185 |
8 | 194873 | 0.180 |
6 | 140904 | 0.175 |
7 | 595605 | 0.170 |
Price($) | Vol. | No. |
---|---|---|
0.205 | 65468 | 2 |
0.210 | 25992 | 3 |
0.215 | 30000 | 1 |
0.220 | 27066 | 4 |
0.225 | 21604 | 2 |
Last trade - 16.10pm 27/09/2024 (20 minute delay) ? |
Featured News
PAR (ASX) Chart |